| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.07 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |